Press Releases

 
Press Releases
  Date Title View
Jan 2, 2008
LEXINGTON, MASS. — Concert Pharmaceuticals, Inc.™, the first company dedicated to creating safer, more effective medicines using precision deuterium chemistry, announced today that it will be presenting at the 26th Annual JPMorgan Healthcare Conference, being held at the Westin St. Francis Hotel in San Francisco. Roger Tung, Ph.D., P...
Jan 3, 2008
LEXINGTON, Mass. — Concert Pharmaceuticals, Inc.™, the first company dedicated to creating safer, more effective medicines using precision deuterium chemistry, announced today the addition of two new members to its Product Advisory Board (PAB). The PAB, now comprising seven members, was established at CoNCERT’s inception as a s...
Mar 11, 2008
LEXINGTON, MASS. — Concert Pharmaceuticals, Inc.™, the first company dedicated to creating safer, more effective medicines using precision deuterium chemistry, announced today that it will be presenting at the Cowen and Company 28th Annual Healthcare Conference, being held at the Boston Marriott Copley Place in Boston, Massachusetts....
Apr 30, 2008
Lexington, Mass –  CoNCERT Pharmaceuticals, Inc., announced the closing of a $37 million Series C financing today.  The Company intends to use the proceeds to further advance its deuterium chemistry platform and product pipeline.  The financing was led by a leading public equity ins...
Jun 24, 2008
June 24, 2008 Lexington, MA – Concert Pharmaceuticals, Inc. announced today that it has been named to the annual FierceBiotech “Fierce ...
Sep 25, 2008
Results Presented at the North American Menopause Society’s 2008 Annual Meeting Orlando, FL – Concert Pharmaceuticals, Inc. announced today the presentation of data from a preclinical study demonstrating the potential of CTP-347, its novel deuterium-containing serotonin modulat...
Sep 25, 2008
Lexington, MA – Concert Pharmaceuticals, Inc. announced today that it has initiated a Phase I study in healthy volunteers to evaluate the safety, tolerability and pharmacokinetics of CTP-347, a novel deuterium-containing serotonin modulator created by Concert researchers.  Concert intends to evaluate CTP...
Sep 29, 2008
Lexington, MA - Concert Pharmaceuticals, Inc. announced today that it will be presenting at the Third Annual JMP Securities Healthcare Focus Conference, being held at the Le Parker Meridien in New York City. Roger Tung, Ph.D., President and Chief Executive Officer of Concert, will present an overview of the Company on Monday, October 6, 200...
Oct 6, 2008
Lexington, MA – Concert Pharmaceuticals, Inc. today announced that Steven B. Bernitz has joined the company as its Senior Vice President and Chief Business Officer.  In this role, he will be a member of Concert’s executive management team, designing and implementing strategic planning initiatives and having overall responsib...
Oct 15, 2008
Lexington, MA – Concert Pharmaceuticals, Inc. today announced that it will be presenting at the 2008 Boston Biotech R&D Conference being held at Harvard Medical School in Cambridge, Massachusetts.  Roger Tung, Ph.D., President and Chief Executive Officer of Concert, will present an overview of the Company on Wednesday, Octobe...
1
...
NextLast
= add release to Briefcase